Incidence of sex chromosome aneuploidy in Northern Italy: 27-year longitudinal study

CONCLUSIONS: Our findings suggest the inclusion of SCAs in prenatal cfDNA screening tests can increase the prenatal identification of affected individuals. As the benefits of early ascertainment are increasingly recognized, it is essential that healthcare providers are equipped with comprehensive and evidence-based information regarding the associated phenotypic differences and the availability of targeted effective interventions to improve neurodevelopmental and health outcomes for affected individuals. This article is protected by copyright. All rights reserved.PMID:36929222 | DOI:10.1002/uog.26201
Source: The Ultrasound Review of Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research